Its significance in antitumor immunity was brought to attention by in vivo experiments where mice deficient in STING [133] or cGAS (cyclic GMP-AMP synthase) [134], an upstream component of the pathway, failed to reject tumor growth. This evidence concerns the gene STING1 and neoplasm.